0001209191-23-033785.txt : 20230602
0001209191-23-033785.hdr.sgml : 20230602
20230602163144
ACCESSION NUMBER: 0001209191-23-033785
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230531
FILED AS OF DATE: 20230602
DATE AS OF CHANGE: 20230602
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Xu Stella
CENTRAL INDEX KEY: 0001728741
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40288
FILM NUMBER: 23989397
MAIL ADDRESS:
STREET 1: C/O ARMO BIOSCIENCES, INC.
STREET 2: 575 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Design Therapeutics, Inc.
CENTRAL INDEX KEY: 0001807120
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 823929248
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6005 HIDDEN VALLEY ROAD
STREET 2: SUITE 110
CITY: CARLSBAD
STATE: CA
ZIP: 92011
BUSINESS PHONE: 858-293-4900
MAIL ADDRESS:
STREET 1: 6005 HIDDEN VALLEY ROAD
STREET 2: SUITE 110
CITY: CARLSBAD
STATE: CA
ZIP: 92011
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-31
0
0001807120
Design Therapeutics, Inc.
DSGN
0001728741
Xu Stella
C/O DESIGN THERAPEUTICS, INC.
6005 HIDDEN VALLEY ROAD, SUITE 110
CARLSBAD
CA
92011
1
0
0
0
0
Stock Option (right to buy)
5.63
2023-05-31
4
A
0
15000
0.00
A
2033-05-30
Common Stock
15000
15000
D
The shares subject to the option vest in equal monthly installments over 12 months following May 31, 2023 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders.
/s/ Mustapha Parekh, Attorney-in-Fact
2023-06-02